These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 228304)

  • 1. Sodium transport inhibitor from bovine hypothalamus.
    Haupert GT; Sancho JM
    Proc Natl Acad Sci U S A; 1979 Sep; 76(9):4658-60. PubMed ID: 228304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial purification and properties of the inhibitors of Na, K-ATPase and ouabain-binding in bovine central nervous system.
    Akagawa K; Hara N; Tsukada Y
    J Neurochem; 1984 Mar; 42(3):775-80. PubMed ID: 6319608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothalamic Na(+)-K(+)-ATPase inhibitor characterized in two-sided liposomes containing pure renal Na(+)-K(+)-ATPase.
    Anner BM; Rey HG; Moosmayer M; Meszoely I; Haupert GT
    Am J Physiol; 1990 Jan; 258(1 Pt 2):F144-53. PubMed ID: 2154124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete purification of two identical Na(+)-pump inhibitors isolated from bovine hypothalamus and hypophysis.
    Illescas M; Ricote M; Mendez E; G-Robles R; Sancho J
    FEBS Lett; 1990 Feb; 261(2):436-40. PubMed ID: 2155831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Purification of an endogenous inhibitor of sodium-potassium-ATPase].
    Cloix JF; Miller ED; Pernollet MG; Devynck MA; Meyer P
    C R Seances Acad Sci III; 1983 Feb; 296(5):213-6. PubMed ID: 6303528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive inotropic effects of the endogenous Na+/K(+)-transporting ATPase inhibitor from the hypothalamus.
    Hallaq HA; Haupert GT
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10080-4. PubMed ID: 2557617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The search for a hypothalamic Na+,K+-ATPase inhibitor.
    Haber E; Haupert GT
    Hypertension; 1987 Apr; 9(4):315-24. PubMed ID: 2435655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothalamic sodium-transport inhibitor is a high-affinity reversible inhibitor of Na+-K+-ATPase.
    Haupert GT; Carilli CT; Cantley LC
    Am J Physiol; 1984 Dec; 247(6 Pt 2):F919-24. PubMed ID: 6095682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Na+ pump in renal tubular cells is regulated by endogenous Na+-K+-ATPase inhibitor from hypothalamus.
    Cantiello HF; Chen E; Ray S; Haupert GT
    Am J Physiol; 1988 Oct; 255(4 Pt 2):F574-80. PubMed ID: 2845805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [(NA++K+)-ATPase inhibitor from bovine hypothalamus].
    Fu Y
    Zhonghua Yi Xue Za Zhi; 1990 Aug; 70(8):442-5, 32. PubMed ID: 2174283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of Na+, K+-ATPase by the endogenous sodium transport inhibitor from hypothalamus.
    Haupert GT
    Hypertension; 1987 Nov; 10(5 Pt 2):I61-6. PubMed ID: 2824368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that the hypothalamus may be a source of a circulating Na+-K+-ATPase inhibitor.
    Alaghband-Zadeh J; Fenton S; Hancock K; Millett J; de Wardener HE
    J Endocrinol; 1983 Aug; 98(2):221-6. PubMed ID: 6308123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kaliuretic peptide: the most potent inhibitor of Na(+)-K+ ATPase of the atrial natriuretic peptides.
    Chiou S; Vesely DL
    Endocrinology; 1995 May; 136(5):2033-9. PubMed ID: 7720651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and partial purification of the sodium-potassium-ATPase inhibitor released from cultured rat hypothalamic cells.
    Morgan K; Lewis MD; Spurlock G; Collins PA; Foord SM; Southgate K; Scanlon MF; Mir MA
    J Biol Chem; 1985 Nov; 260(25):13595-600. PubMed ID: 2997173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release of an active sodium transport inhibitor (ASTI) from rat hypothalamic cells in culture.
    Morgan K; Foord SM; Spurlock G; Charalambous BM; Dieguez C; Scanlon MF; Mir MA
    Endocrinology; 1984 Oct; 115(4):1642-4. PubMed ID: 6148236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A non-ouabain Na/K ATPase inhibitor isolated from bovine hypothalamus. Its relation to hypothalamic ouabain.
    Sancho JM
    Clin Exp Hypertens; 1998; 20(5-6):535-42. PubMed ID: 9682909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of the purified hypothalamic pituitary NA/K-ATPase inhibitor.
    Sancho JM; Garcia-Martin E; Garcia-Robles R; Santirso R; Villa E; Gutierrez-Merino C; Ricote M
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S32-4. PubMed ID: 7508022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ouabainlike factor in Milan hypertensive rats.
    Ferrandi M; Minotti E; Salardi S; Florio M; Bianchi G; Ferrari P
    Am J Physiol; 1992 Oct; 263(4 Pt 2):F739-48. PubMed ID: 1329560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Observations on a low molecular weight natriuretic and Na-K-ATPase inhibitory material in urine.
    Clarkson EM; de Wardener HE
    Clin Exp Hypertens A; 1985; 7(5-6):673-83. PubMed ID: 2990768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Franz Volhard Lecture 1996. Sodium transport inhibitors and hypertension.
    de Wardener HE
    J Hypertens Suppl; 1996 Dec; 14(5):S9-18. PubMed ID: 9120690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.